Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 17-May-24 4:00 PM View:  | Effector Therapeutics, Inc. (EFTR) | 15-May-24 | Grant | 1,387 | $1.68 | $2,334.32 | 80% 1.73K to 3.12K | |
| 16-Nov-23 5:26 PM View: | Effector Therapeutics, Inc. (EFTR) | 15-Nov-23 | Grant | 4,524 | $0.50 | $2,249.79 | 12% 38.75K to 43.27K | |
| 16-May-23 8:01 AM View: | Effector Therapeutics, Inc. (EFTR) | 15-May-23 | Grant | 4,863 | $0.46 | $2,232.12 | 14% 33.88K to 38.75K | |
| 16-Nov-22 6:30 PM View: | Effector Therapeutics, Inc. (EFTR) | 15-Nov-22 | Grant | 4,651 | $0.47 | $2,178.53 | 16% 29.23K to 33.88K | |
| 07-Jun-22 5:30 PM View: | Effector Therapeutics, Inc. (EFTR) | 07-Jun-22 | Private Purchase | 25,000 | $1.33 | $33,262.50 | 591% 4.23K to 29.23K | |
| 17-May-22 8:46 PM View: | Effector Therapeutics, Inc. (EFTR) | 13-May-22 | Grant | 4,233 | $1.53 | $6,476.49 | 100% 0 to 4.23K | |
| 11-Dec-17 3:23 PM View: | Tranzyme, Inc. (OCRX) | 11-Dec-17 | Disposition | 163,000 | $1.52 | $247,760.00 | (100%) 163.0K to 0 | |
| 30-Mar-17 5:16 PM View: | Tranzyme, Inc. (OCRX) | 29-Mar-17 | Grant | 150,000 | -- | -- | 1154% 13.0K to 163.0K | |
| 28-Mar-17 4:06 PM View: | Tranzyme, Inc. (OCRX) | 28-Mar-17 | Market Purchase | 3,000 | $1.28 | $3,854.40 | 30% 10.0K to 13.0K | 39% |
| 19-Jan-16 8:14 AM View: | Tranzyme, Inc. (OCRX) | 15-Jan-16 | Market Purchase | 3,500 | $2.07 | $7,245.00 | 54% 6.5K to 10.0K | (14%) |
| 06-May-15 6:03 PM View: | Tranzyme, Inc. (OCRX) | 06-May-15 | Market Purchase | 2,500 | $3.61 | $9,025.00 | 62% 4.0K to 6.5K | (50%) |
| 02-Oct-14 4:16 PM View: | Tranzyme, Inc. (OCRX) | 01-Oct-14 | Market Purchase | 2,000 | $4.81 | $9,620.00 | 100% 2.0K to 4.0K | (63%) |